Relationship between baseline bone turnover marker levels and percent change in BMD at month 12 in postmenopausal women transitioned to denosumab or continuing on long-term alendronate therapy

Saved in:
Bibliographic Details
Published in:Bone (New York, N.Y.) N.Y.), 2009-06, Vol.44, p.S435-S435
Main Authors: Roux, C, Bolognese, M.A, Bianchi, G, Supronik, J, Valter, I, de Vernejoul, M.C, Kendler, D.L, Bone, H.G, Ortolani, S, Siddhanti, S, Man, H.S, San Martin, J, Brandi, M.L
Format: Article
Language:English
Subjects:
Orthopedics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:8756-3282
1873-2763
DOI:10.1016/j.bone.2009.03.388